Month: April 2021

One of the most talked about food allergies is peanut. Though not the most common food allergy, it’s the most common food associated with severe allergic reactions – so it’s an important one to be educated on. Consider this overview on peanut allergy: from symptoms, diagnosis, and avoiding peanuts, to options for treating the cause.
0 Comments
A couple of weeks ago, I received a text from my aunt that included a link to a physician-created YouTube video about the COVID vaccine. This creator has built her fame and fortune as an anti-vaccination proponent. Knowing that her videos are rubbish, I ignored the text. A couple of days ago, though, I received
0 Comments
Award-winning journalist, competitive amateur powerlifter and author Poorna Bell joins Happiful’s podcast to talk about embracing gratitude and growing stronger through change Poorna Bell’s new book Stronger: Changing Everything I Thought I Knew About Women’s Strength has a vibrant energy about it, even upon first sight. With a vivid yellow lightning bolt emblazoned on the
0 Comments
The limitations of biventricular (BiV) pacing, successful as it has been at improving cardiac function and outcomes in many patients with heart failure, leave opportunities for more physiologic pacing alternatives to drive cardiac resynchronization therapy (CRT). Both His bundle pacing (HBP) and left bundle pacing (LBP) have emerged as candidates in recent years, not as
0 Comments
Root Sciences and Ecodyst have joined forces to provide hi-speed evaporators to the market for solvent recovery in cannabinoid applications. Solvent recovery is a common bottleneck in many cannabis processing operations. The unique line of products manufactured by Ecodyst provides single equipment solutions for solvent recovery, decarboxylation, and devolatilization to prepare crude oil for molecular
0 Comments
FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after
0 Comments
In this article RCL The Mariner of the Seas cruise ship, operated by Royal Caribbean Cruises Ltd. and host to the Coinsbank Blockchain Cruise Asia, sits off Paradise Beach in Phuket, Thailand, on Wednesday, Jan. 17, 2018. When 600 cryptocurrency enthusiasts set sail from Singapore on Monday night for their second annual Blockchain Cruise, the
0 Comments
With each wave of COVID-19 cases, hospitals have scrambled to add more beds while simultaneously cancelling surgeries. The latest example is Michigan, where hospitals postponed procedures because of the crush of COVID-19 patients filling beds and emergency rooms. Non-COVID-19 patients are at best inconvenienced by the postponements, and at worst imperiled. Hospitals now face a
0 Comments
Moon mentor Kirsty Gallagher shares her passion for lunar living, and how setting our sights to the skies could actually reinforce the connection to ourselves Over the past year, have you found yourself tuning-in to nature more than you did before? Have you found yourself really hearing the birds, noticing each morning becoming a bit
0 Comments
The investigational drug tolebrutinib effectively reduces brain lesions in patients with highly active relapsing-remitting multiple sclerosis (RRMS), new research suggests. After 12 weeks of treatment, MRI revealed the drug, a Bruton’s tyrosine kinase (BTK) inhibitor, was associated with a 93% reduction in new gadolinium-enhancing lesions and an 89% reduction in new and enlarging T2 lesions
0 Comments
It’s been a decade since e-cigarettes first gained popularity in the UK. Since then, the types of devices available and the number of people using them has risen sharply. And as the popularity levels of e-cigarettes grew, so did the debate around them. The big selling point for e-cigarettes is they’re a way to help
0 Comments
KENILWORTH, N.J., & MIAMI–(BUSINESS WIRE) April 15, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today provided an update on the clinical development program for molnupiravir (MK-4482/ EIDD-2801), an investigational orally available antiviral therapeutic. Based on a planned interim analysis of data from the Phase 2,
0 Comments
Mothers’ dietary and television-watching habits had an effect on the body mass index (BMI) and lifestyle patterns of their young children, according to a trajectory modeling study. In more than 400 children and mothers followed for 5 years, the kids of mothers who followed a healthy dietary pattern high in fruits and vegetables were more
0 Comments